Welcome to LookChem.com Sign In|Join Free

CAS

  • or

182181-25-5

Post Buying Request

182181-25-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

182181-25-5 Usage

General Description

6-CHLORO-2-(CHLOROMETHYL)IMIDAZO[1,2-A]PYRIDINE is a chemical compound with the molecular formula C8H5Cl2N3. It is a chloro-substituted imidazopyridine derivative, which is commonly used in the pharmaceutical industry for the synthesis of various drugs and agrochemicals. 6-CHLORO-2-(CHLOROMETHYL)IMIDAZO[1,2-A]PYRIDINE is known for its potent biological activities and is often used as a building block in the development of new therapeutic agents. It exhibits significant antibacterial, antifungal, and antiparasitic properties, making it a valuable chemical in drug discovery and development. Additionally, 6-CHLORO-2-(CHLOROMETHYL)IMIDAZO[1,2-A]PYRIDINE is also used in the synthesis of various specialty chemicals and is a versatile building block in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 182181-25-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,2,1,8 and 1 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 182181-25:
(8*1)+(7*8)+(6*2)+(5*1)+(4*8)+(3*1)+(2*2)+(1*5)=125
125 % 10 = 5
So 182181-25-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H6Cl2N2/c9-3-7-5-12-4-6(10)1-2-8(12)11-7/h1-2,4-5H,3H2

182181-25-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-CHLORO-2-(CHLOROMETHYL)IMIDAZO[1,2-A]PYRIDINE

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:182181-25-5 SDS

182181-25-5Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF AMYLOID-RELATED DISEASES

-

Paragraph 0186, (2020/08/28)

A compound of Formula (I) or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series

Castera-Ducros, Caroline,Paloque, Lucie,Verhaeghe, Pierre,Casanova, Magali,Cantelli, Christophe,Hutter, Sébastien,Tanguy, Floriane,Laget, Michèle,Remusat, Vincent,Cohen, Anita,Crozet, Maxime D.,Rathelot, Pascal,Azas, Nadine,Vanelle, Patrice

, p. 7155 - 7164 (2013/11/06)

We report herein the discovery of antileishmanial molecules based on the imidazo[1,2-a]pyridine ring. In vitro screenings of imidazopyridines belonging to our chemical library, toward the promastigotes stage of Leishmania donovani, J774A.1 murine and HepG2 human cells, permitted to identify three selective hit-compounds (12, 20 and 28). New derivatives were then synthesized to allow structure-activity and -toxicity relationships analyses, enabling to characterize a lead-compound (44) displaying both a high potency (IC 50 = 1.8 μM) and a good selectivity index, in comparison with three antileishmanial reference drug-compounds (amphotericin B, miltefosine and pentamidine). Moreover, lead-compound 44 also exhibits good in vitro activity against the intracellular amastigote stage of L. donovani. Thus, the 6-halo-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridine scaffold appears as a new promising selective antileishmanial pharmacophore, especially when substituted at position 8 by a bromine atom.

IMIDAZO[1,2-A]PYRIDINES FOR THE TREATMENT OF CNS AND CARDIAC DISEASES

-

, (2008/06/13)

The present invention relates to imidazo[1,2-a]pyridine compounds of formula (1) STR1 which are dopamine D-4 antagonists and useful as anti-psychotic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 182181-25-5